Showing results (211-220 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 19, 2016
Constructing Tumor Vaccines Targeting for Vascular Endothelial Growth Factor (VEGF) by DNA ShufflingNana Bie, Xiuyun Zhao, Zhitao Li, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 29, 1998
Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2N L Harthun, A M Weaver, L H Brinckerhoff, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 29, 1998
Cyclophosphamide enhances the CTL precursor frequency in mice immunized with MUC1-mannan fusion protein (M-FP)V Apostolopoulos, V Popovski, I F McKenzieJournal of Immunotherapy (Hagerstown, Md. : 1997)|April 29, 1998
TAP-independent delivery of antigenic peptides to the endoplasmic reticulum: therapeutic potential and insights into TAP-dependent antigen processingJ W Yewdell, H L Snyder, I Bacik, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinaseJ P Riley, S A Rosenberg, M R ParkhurstJournal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Polyclonal antibodies against gp185HER2 peptides: their putative role in the identification of a particular HER2 status in patients with breast cancerF Di Modugno, S Buglioni, M Mottolese, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigensL A Lambert, G R Gibson, M Maloney, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Avoiding tolerance against prostatic antigens with subdominant peptide epitopesM E Grossmann, T Davila, T CelisJournal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Low-dose vaccinia virus-mediated cytokine gene therapy of gliomaB Chen, T M Timiryasova, P Haghighat, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanomaR Lau, F Wang, G Jeffery, et al.Pageof 175